PCM
PRNB

Prelude Capital Management’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Prelude Capital Management’s Portfolio PRNB Stock Details PRNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-6,490
Closed -$388K – 2600
2020
Q2 		$388K Sell
6,490
-507
-7% -$31.3K 0.02% 547
2020
Q1 		$415K Buy
+6,997
New +$408K 0.03% 342

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS)
Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ADL
Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

Prelude Capital Management's PRNB Position: Q3 2020 in Review

Prelude Capital Management sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 6,490 shares — an estimated $388K sold.

Prelude Capital Management first reported a position in PRNB in Q1 2020 and held it in 2 quarters. The position peaked at $415K in Q1 2020. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

  • Prelude Capital Management reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Prelude Capital Management sold 6,490 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $388K.
  • Prelude Capital Management first reported a position in Principia Biopharma Inc. Common Stock in Q1 2020 and held it in 2 quarters.
  • Prelude Capital Management's Principia Biopharma Inc. Common Stock position peaked at $415K in Q1 2020.
  • 9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on Prelude Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.